KOS-1584

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KOS-1584, covering 2016-05-17 to 2016-05-17. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

See pricing